Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIOSE CUTÂNEA, ANTIMÔNIO, NANOPARTÍCULAS, INFECÇÕES POR PROTOZOÁRIOS, DOENÇAS PARASITÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOROIWA, Thais Aragão et al. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, v. 147, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105295. Acesso em: 31 out. 2024.APA
Horoiwa, T. A., Cortez, M., Sauter, I. P., Migotto, A., Bandeira, C. L., Cerize, N. N. P., & Oliveira, A. M. de. (2020). Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, 147, 9 . doi:10.1016/j.ejps.2020.105295NLM
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295Vancouver
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295